Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Extension of Afegostat Tartrate in Type 1 Gaucher Disease
NCT00813865Phase 2Completed
- Sponsor
- Amicus Therapeutics
- Start
- May 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Afegostat in Gaucher disease type 1 (GD1), sponsored by Amicus Therapeutics. Started May 2009; status: completed.
02
Drugs
Afegostat
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00813865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813865.